Please use this identifier to cite or link to this item:
Type
ArticleCopyright
Restricted access
Collections
- IOC - Artigos de Periódicos [12968]
Metadata
Show full item record
PROTEINASE INHIBITORS: A PROMISING DRUG CLASS FOR TREATING LEISHMANIASIS
Author
Affilliation
Abstract
This review presents and discusses the current status and perspectives of leishmaniasis treatment, with a special
focus on the use of proteinase inhibitors. The history of treatment development, the first- and second-choice modern drugs
and the advantages and disadvantages of using proteinases inhibitors as leishmanicidal treatments are presented and discussed.
The reports gathered herein confirm the potential usefulness of proteinases inhibitors as an alternative or complement
to the current leishmaniasis treatments. They also support the hypothesis that a combined treatment with multiple
proteinase inhibitors may be efficient against Leishmania infections in vertebrate hosts.
Share